Restoring Dystrophin via Exon Skipping Strategies AOC 1044 – Mark Stahl, MD (Avidity Biosciences) BMN 351 – Dave Jacoby MD, PhD (BioMarin Pharmaceutical Inc.) DYNE-251 – Ash Dugar, PhD, MBA (Dyne Therapeutics) ED051 – Michelle Mellion, MD (PepGen, Inc.) ENTR-601-44 – Nerissa Kreher, MD, MBA (Entrada Therapeutics) SRP-5051 – Teji Singh, MD (Sarepta Therapeutics) WVE-N531 – Mike Panzara, MD, MPH (Wave Life Sciences) 2022 PPMD Annual Conference,Conferences & Meetings 2 years ago You may also like 14:12 Closing Address: Looking Ahead to 2021 4 years ago 2020 PPMD Virtual Conference: Live Sessions,Conferences & Meetings 26:14 Imaging DMD 4 years ago Conferences & Meetings,Resources & Tools 45:00 Gene Therapy: Q&A 4 years ago Conferences & Meetings,In the Pipeline: Gene Therapy gene therapy 44:59 CINRG Expanded Duchenne Natural History Study (eDNHS) 4 years ago Conferences & Meetings,Foundations of Drug Development 37:11 Genetics & The Duchenne Registry 4 years ago Beginning the Duchenne Journey,Conferences & Meetings 24:30 Research & Clinical Trials 4 years ago Beginning the Duchenne Journey,Conferences & Meetings 4:10 PPMD Community: Getting Involved 4 years ago Beginning the Duchenne Journey,Conferences & Meetings 22:23 Advocacy & Community Engagement 4 years ago Beginning the Duchenne Journey,Conferences & Meetings «1…1516171819…25»Page 17 of 25
by: Parent Project Muscular Dystrophy
